By Evan Weinberger ( June 7, 2010, 5:18 PM EDT) -- Spanish health care company Grifols SA announced Monday that it had agreed to purchase Talecris Biotherapeutics for approximately $3.4 billion, nearly a year after a previous buyer for the Cerberus Capital Management LP dropped out under regulatory scrutiny....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.